Evidence map›Paper›PMID 40699203›Full record

ArticleThe Journal of international medical research2025

Multiple occurrences of membranous nephropathy complicated with anti-glomerular basement membrane antibody and anti-neutrophil cytoplasm antibody double-negative crescentic formation since the COVID-19 pandemic: A case series.

Shuang Yuan, Chao Li, ZhiBo Guo, Guang Yang, LiHong Zhang, Tao Wang

Abstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuang YuanGraduate School of Hebei Medical University, P.R. China.
Chao LiThe Second Department of Diagnostic and Therapeutic Gastroenterology, the First Hospital of Hebei Medical University, P.R. China.
ZhiBo GuoDepartment of Nephrology, Municipal Hospital of GaoBeiDian, P.R. China.
Guang YangTaiYuan KingMed Center for Clinical Laboratory, P.R. China.
LiHong ZhangDepartment of Nephrology, the First Hospital of Hebei Medical University, P.R. China.
Tao WangDepartment of Nephrology, the First Hospital of Hebei Medical University, P.R. China.ORCID 0000-0002-7370-7299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been an unusual increase in the incidence of anti-glomerular basement membrane disease, anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis, and double-positive cases since the coronavirus disease 2019 (COVID-19) pandemic. Rare cases have been consistently reported, including anti-glomerular basement membrane antibody and ANCA double-positive crescentic glomerulonephritis after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as well as coexistent membranous nephropathy and proteinase 3 ANCA-associated crescentic glomerulonephritis following vaccination. We described both anti-phospholipase A2 receptor (PLA2R) antibody-positive and -negative membranous nephropathy superimposed on anti-glomerular basement membrane disease. Upon and beyond these findings, we herein reported three cases of biopsy-confirmed membranous nephropathy concurrent with anti-glomerular basement membrane antibody and ANCA double-negative crescentic formation, which manifested as acute kidney injury clinically. In one case, repeated renal biopsies confirmed

Indexed as

Antibodies, Antineutrophil CytoplasmicAutoantibodiesCOVID-19Glomerulonephritis, MembranousAdultAgedFemaleHumansMaleMiddle AgedReceptors, Phospholipase A2SARS-CoV-2Antibodies, Antineutrophil Cytoplasmicantiglomerular basement membrane antibodyAutoantibodiesReceptors, Phospholipase A2acute kidney injuryanti-CD20 monoclonal antibodyCoronavirus disease 2019crescentic formationmembranous nephropathyphospholipase 2 receptorrenal pathology

Identifiers

PMID40699203
PMCPMC12301590

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.